Vacuum drainage in the management of complicated abdominal wound dehiscence in children.
Abstract
[PURPOSE] The aim of the study was to report the outcomes of the vacuum dressing method (vacuum-assisted closure [VAC]) in the management of "complicated" abdominal wounds in a selected group of children including neonates.
[METHODS] All children with vacuum (VAC) dressing-assisted closure of a complex abdominal wound (defined as complete/partial wound dehiscence combined with at least one of stoma, anastomosis, tube enterostomy, or infected patch abdominoplasty) were included in a 2-year study that took place in a single tertiary referral hospital. Retrospective case note analysis was used to determine premorbid diagnosis, management, illness severity markers, morbidity, and outcome.
[RESULTS] Nine children (neonate to 16 years) required 11 continuous episodes of VAC therapy. Abdominal wall dehiscence was complete in 7 and partial in 4 episodes. These were complicated by stomas (8), anastomoses (3), enterocutaneous fistulae (3), tube enterostomy (1), and infected patch abdominoplasty (2). Illness severity was assessed by the following proxy physiologic markers: American Society of Anesthesiologists status 3 or more (10), intensive care unit (ICU) (7), inotropes (4), ventilation (7), septic (C-reactive protein >100 and blood culture-positive) (3), liver impairment (aspartate transaminase >58 and alanine transaminase >36) (4), coagulopathy (international normalized ratio >1.3) (4), proinflammatory state (platelet count >450) (5), and nutritional impairment (albumin <37) (9). The median VAC treatment time was 32 days (range, 9-101 days). Of the changes, 70% required a general anesthetic or sedation on ICU. Control of 10 of 11 complex abdominal wounds (including 3 established enterocutaneous fistulae) was achieved using VAC therapy. Complications included nonreduction of laparostomy (1), failure of anastomosis (1), and failure of tube enterostomy diversion (1). Four children died of unrelated causes, 2 of them more than 3 months after VAC therapy.
[CONCLUSIONS] In our experience with a small series of patients, VAC therapy is both safe and effective in complex pediatric abdominal wounds in severely ill children. It appears to promote wound closure, controls local sepsis, and can be used to manage established fistulae. However, our results suggest that recent bowel anastomoses may be compromised using VAC, which in this circumstance, should be used with caution.
[METHODS] All children with vacuum (VAC) dressing-assisted closure of a complex abdominal wound (defined as complete/partial wound dehiscence combined with at least one of stoma, anastomosis, tube enterostomy, or infected patch abdominoplasty) were included in a 2-year study that took place in a single tertiary referral hospital. Retrospective case note analysis was used to determine premorbid diagnosis, management, illness severity markers, morbidity, and outcome.
[RESULTS] Nine children (neonate to 16 years) required 11 continuous episodes of VAC therapy. Abdominal wall dehiscence was complete in 7 and partial in 4 episodes. These were complicated by stomas (8), anastomoses (3), enterocutaneous fistulae (3), tube enterostomy (1), and infected patch abdominoplasty (2). Illness severity was assessed by the following proxy physiologic markers: American Society of Anesthesiologists status 3 or more (10), intensive care unit (ICU) (7), inotropes (4), ventilation (7), septic (C-reactive protein >100 and blood culture-positive) (3), liver impairment (aspartate transaminase >58 and alanine transaminase >36) (4), coagulopathy (international normalized ratio >1.3) (4), proinflammatory state (platelet count >450) (5), and nutritional impairment (albumin <37) (9). The median VAC treatment time was 32 days (range, 9-101 days). Of the changes, 70% required a general anesthetic or sedation on ICU. Control of 10 of 11 complex abdominal wounds (including 3 established enterocutaneous fistulae) was achieved using VAC therapy. Complications included nonreduction of laparostomy (1), failure of anastomosis (1), and failure of tube enterostomy diversion (1). Four children died of unrelated causes, 2 of them more than 3 months after VAC therapy.
[CONCLUSIONS] In our experience with a small series of patients, VAC therapy is both safe and effective in complex pediatric abdominal wounds in severely ill children. It appears to promote wound closure, controls local sepsis, and can be used to manage established fistulae. However, our results suggest that recent bowel anastomoses may be compromised using VAC, which in this circumstance, should be used with caution.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | abdominoplasty
|
복부성형술 | dict | 2 | |
| 합병증 | wound dehiscence
|
상처열개 | dict | 2 | |
| 해부 | tube
|
scispacy | 1 | ||
| 해부 | blood
|
scispacy | 1 | ||
| 해부 | liver
|
scispacy | 1 | ||
| 해부 | bowel
|
scispacy | 1 | ||
| 합병증 | dehiscence
|
상처열개 | dict | 1 | |
| 합병증 | abdominal wound
|
scispacy | 1 | ||
| 합병증 | vacuum-assisted
|
scispacy | 1 | ||
| 합병증 | abdominal wounds
|
scispacy | 1 | ||
| 합병증 | wound
|
scispacy | 1 | ||
| 합병증 | enterocutaneous fistulae
|
scispacy | 1 | ||
| 합병증 | wounds
|
scispacy | 1 | ||
| 합병증 | fistulae
|
scispacy | 1 | ||
| 약물 | VAC
→ vacuum
|
C0042221
Vacuum (physical force)
|
scispacy | 1 | |
| 약물 | aspartate
|
C0085845
aspartate
|
scispacy | 1 | |
| 약물 | alanine
|
C0001898
alanine
|
scispacy | 1 | |
| 약물 | [PURPOSE] The
|
scispacy | 1 | ||
| 약물 | aspartate transaminase
|
scispacy | 1 | ||
| 약물 | alanine transaminase >36
|
scispacy | 1 | ||
| 질환 | stoma
|
C1955856
Surgical Stoma
|
scispacy | 1 | |
| 질환 | septic
|
C0333534
septic
|
scispacy | 1 | |
| 질환 | liver impairment
|
scispacy | 1 | ||
| 질환 | coagulopathy
|
C0005779
Blood Coagulation Disorders
|
scispacy | 1 | |
| 질환 | nutritional impairment
|
scispacy | 1 | ||
| 질환 | failure of anastomosis (1), and failure of tube enterostomy diversion
|
scispacy | 1 | ||
| 질환 | sepsis
|
C0036690
Septicemia
|
scispacy | 1 | |
| 기타 | children
|
scispacy | 1 | ||
| 기타 | neonates
|
scispacy | 1 | ||
| 기타 | neonate
|
scispacy | 1 | ||
| 기타 | Abdominal wall
|
scispacy | 1 | ||
| 기타 | platelet count >450
|
scispacy | 1 | ||
| 기타 | albumin
|
scispacy | 1 |
MeSH Terms
Abdominal Injuries; Abdominal Wall; Adolescent; Child; Child, Preschool; Drainage; Female; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Severity of Illness Index; Surgical Wound Dehiscence; Surgical Wound Infection; Treatment Outcome; Vacuum
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- What is the potential role of the nonopioid suzetrigine in pain management?
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.
- Pedicled extensor digitorum brevis flap for the distal third lower limb reconstruction: A review of the literature.